Antagonists of the prostaglandin D2 receptor CRTH2

Progress in Respiratory Research

Volumn 39, Issue , 2010, Pages 193-198

  Pettipher, Roy ^a   Hansel, Trevor T ^b  

^a Oxagen Ltd   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956463009     PISSN: 14222140     EISSN: 16623932     Source Type: Book Series    
DOI: 10.1159/000320819     Document Type: Article

References (42)

1. Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, Roberts LJ. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 1982, 129(4): 1627-31.
2. Peters SP, Schleimer RP, Kagey-Sobotka A et al. The role of prostaglandin D2 in IgE-mediated reactions in man. Trans Assoc Am Physicians 1982, 95: 221-8.
3. O'Sullivan S, Dahlen B, Dahlen SE, Kumlin M. Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J Allergy Clin Immunol 1996, 98(2): 421-32.
4. Bochenek G, Nagraba K, Nizankowska E, Szczeklik A. A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. J Allergy Clin Immunol 2003, 111(4): 743-9.
5. Dahlen SE, Kumlin M. Monitoring mast cell activation by prostaglandin D2 in vivo. Thorax 2004, 59(6): 453-5.
6. Reddy ST, Tiano HF, Langenbach R, Morham SG, Herschman HR. Genetic evidence for distinct roles of COX-1 and COX-2 in the immediate and delayed phases of prostaglandin synthesis in mast cells. Biochem Biophys Res Commun 1999, 265(1): 205-10.
7. Murray JJ, Tonnel AB, Brash AR. et al. Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med 1986, 315(13): 800-4.
8. Naclerio RM, Meier HL, Kagey-Sobotka A, Adkinson NF Jr., Meyers DA, Norman PS, Lichtenstein LM. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983, 128(4): 597-602.
9. Charlesworth EN, Kagey-Sobotka A, Schleimer RP, Norman PS, Lichtenstein LM. Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. J Immunol 1991, 146(2): 671-6.
10. Tanaka K, Ogawa K, Sugamura K, Nakamura M, Takano S, Nagata K. Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets. J Immunol 2000, 164(5): 2277-80.
11. Wang YH, Ito T, Wang YH. et al. Maintenance and polarization of human t(h)2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity 2006, 24(6): 827-38.
12. Hirai H, Tanaka K, Yoshie O et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001, 193(2): 255-61.
13. Gazi L, Gyles S, Rose J. et al. Delta12-prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes. Prostaglandins Other Lipid Mediat 2005, 75(1-4): 153-67.
14. Heinemann A, Schuligoi R, Sabroe I, Hartnell A, Peskar BA. Delta12- prostaglandin J2, a plasma metabolite of prostaglandin D2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis. J Immunol 2003, 170(9): 4752-8.
15. Monneret G, Li H, Vasilescu J, Rokach J, Powell WS. 15-Deoxy-delta 12,14- prostaglandins D2 and J2 are potent activators of human eosinophils. J Immunol 2002, 168(7): 3563-9.
16. Schuligoi R, Schmidt R, Geisslinger G, Kollroser M, Peskar BA, Heinemann A. PGD2 metabolism in plasma: Kinetics and relationship with bioactivity on DP1 and CRTH2 receptors. Biochem Pharmacol 2007, 74(1): 107-17.
17. Bohm E, Sturm GJ, Weiglhofer I. et al. 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. J Biol Chem 2004, 279(9): 7663-70.
18. Sandig H, Andrew D, Barnes AA, Sabroe I, Pease J. 9alpha,11beta-PGF2 and its stereoisomer PGF2? are novel agonists of the chemoattractant receptor, CRTH2. FEBS Lett 2006, 580(2): 373-9.
19. Cossette C, Walsh SE, Kim S. et al. Agonist and antagonist effects of 15Rprostaglandin (PG) D2 and 11-methylene-PGD2 on human eosinophils and basophils. J Pharmacol Exp Ther 2007, 320(1): 173-9.
20. Nagata K, Hirai H, Tanaka K. et al. CRTH2, an orphan receptor of T-helper-2- cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett 1999, 459(2): 195-9.
21. Nagata K, Tanaka K, Ogawa K. et al. Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol 1999, 162(3): 1278-86.
22. Sawyer N, Cauchon E, Chateauneuf A. et al. Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br J Pharmacol 2002, 137(8): 1163-72.
23. Xue L, Gyles SL, Barrow A, Pettipher R. Inhibition of PI3K and calcineurin suppresses chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)-dependent responses of Th2 lymphocytes to prostaglandin D2. Biochem Pharmacol 2007, 73(6): 843-53.
24. Kostenis E, Ulven T. Emerging roles of DP and CRTH2 in allergic inflammation. Trends Mol Med 2006, 12(4): 148-58.
25. Nantel F, Fong C, Lamontagne S. et al. Expression of prostaglandin D synthase and the prostaglandin D2 receptors DP and CRTH2 in human nasal mucosa. Prostaglandins Other Lipid Mediat 2004, 73(1-2): 87-101.
26. Okano M, Fujiwara T, Sugata Y. et al. Presence and characterization of prostaglandin D2-related molecules in nasal mucosa of patients with allergic rhinitis. Am J Rhinol 2006, 20(3): 342-8.
27. Iwasaki M, Nagata K, Takano S, Takahashi K, Ishii N, Ikezawa Z. Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. J Invest Dermatol 2002, 119(3): 609-16.
28. Vinall SL, Townsend ER, Pettipher R. A paracrine role for chemoattractant receptor-homologous molecule expressed on T helper type 2 cells (CRTH2) in mediating chemotactic activation of CRTH2(+) CD4(+) T helper type 2 lymphocytes. Immunology 2007, 121(4): 577-84.
29. Xue L, Gyles SL, Wettey FR, Gazi L, Townsend E, Hunter MG, Pettipher R. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J Immunol 2005, 175: 6531-6.
30. Monneret G, Gravel S, Diamond M, Rokach J, Powell WS. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 2001, 98(6): 1942-8.
31. Almishri W, Cossette C, Rokach J, Martin JG, Hamid Q, Powell WS. Effects of prostaglandin D2, 15-deoxy-Delta12,14-prostaglandin J2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats. J Pharmacol Exp Ther 2005, 313(1): 64-9.
32. Shiraishi Y, Asano K, Nakajima T. et al. Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor. J Pharmacol Exp Ther 2005, 312(3): 954-60.
33. Gyles SL, Xue L, Townsend ER, Wettey F, Pettipher R. A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants. Immunology 2006, 119(3): 362-8.
34. Narita S, Asakura K, Kataura A. Effects of thromboxane A2 receptor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs. Int Arch Allergy Immunol 1996, 109(2): 161-6.
35. Nagai H, Takeda H, Yamaguchi S, Tanaka H, Matsuo A, Inagaki N. The effect of a thromboxane A2 receptor antagonist BAY-u-3405 on experimental allergic reactions. Prostaglandins 1995, 50(2): 75-87.
36. Takeshita K, Yamasaki T, Nagao K, Sugimoto H, Shichijo M, Gantner F, Bacon KB. CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. Int Immunol 2004, 16(7): 947-59.
37. Uller L, Mathiesen JM, Alenmyr L. et al. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation. Respir Res 2007, 8: 16.
38. Pettipher R, Hansel TT, Armer R. Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. Nat Rev Drug Discov 2007, 6(4): 313-25.
39. Armer RE, Ashton MR, Boyd EA. et al. Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2. J Med Chem 2005, 48(20): 6174-7.
40. Gonzalo J, Qiu Y, Coyle AJ, Hodge MR. CRTH2(DP2) and not DP1 receptor mediate allergen induced mucus production and airway hyperresponsiveness. Am J Respir Crit Care Med 2005, 163(5): A811.
41. Satoh T, Moroi R, Aritake K. et al. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J Immunol 2006, 177(4): 2621-9.
42. Terada N, Yamakoshi T, Hasegawa M, Tanikawa H, Maesako K, Ishikawa K, Konno A. The effect of ramatroban (BAY u 3405), a thromboxane A2 receptor antagonist, on nasal cavity volume and minimum cross-sectional area and nasal mucosal hemodynamics after nasal mucosal allergen challenge in patients with perennial allergic rhinitis. Acta Otolaryngol Suppl 1998, 537: 32-7.